NPR Drug Safety Broadcast: Should the FDA Do More to Identify Unsafe Drugs

NPR Drug Safety Broadcast: Should the FDA Do More to Identify Unsafe Drugs

Speaking Engagement
WilmerHale partner Scott Lassmanspoke during this discussion about the safety of presciption drugs and the changes the FDA should make to ensure the safety of medicine.

Read More About the Event

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.